Atlanta Braves (BATRK) Officer Exercises Options and Sells 60,000 Shares
Rhea-AI Filing Summary
Gregory John Heller, EVP, CLO & Secretary of Atlanta Braves Holdings, Inc. (BATRK), exercised options and sold shares on 08/21/2025. He exercised a stock option with a $27.18 exercise price to acquire 60,000 shares of Series C common stock and immediately sold 60,000 shares at a weighted average sale price of $43.45, with the sale price range reported as $43.09 to $43.70. After these transactions he beneficially owned 14,876 shares of Series C common stock directly and 80,263 shares through previously held derivative securities or other holdings.
The Form 4 was signed by an attorney-in-fact on 08/22/2025 and discloses the option grant’s original grant date (12/10/2023) and option expiration date (12/10/2027). The filing notes the reported sale price is a weighted average and that detailed per-price sale breakdowns are available upon regulatory request.
Positive
- Transaction fully disclosed: Form 4 includes exercise price ($27.18), sale weighted average price ($43.45), and price range ($43.09–$43.70).
- Post-transaction ownership reported: Beneficial ownership shown as 14,876 direct shares and 80,263 shares related to derivative holdings.
Negative
- Insider sale of 60,000 shares: The reporting person sold all 60,000 shares acquired by exercise, reducing direct holdings to 14,876 shares.
- Filing reflects insider liquidity, not company performance: The document does not provide operational or financial metrics to explain the sale.
Insights
TL;DR: Insider exercised options at $27.18 and sold 60,000 shares at a weighted average $43.45, realizing an immediate gain.
The transaction shows a typical option exercise followed by a sale covering the exercised shares. The filing explicitly reports the exercise price of $27.18 and the weighted average sale price of $43.45 (range $43.09–$43.70), indicating the insider captured a spread between exercise and sale prices. Post-transaction beneficial ownership is broken out as 14,876 shares direct and 80,263 shares associated with derivative holdings. For investors, this is a disclosure of insider liquidity rather than an operational signal; the filing contains no other company performance metrics.
TL;DR: Disclosure is complete for the reported exercise and sale; it documents both option terms and remaining beneficial ownership.
The Form 4 provides required detail: transaction date 08/21/2025, option exercise and sale codes, original option grant date (12/10/2023), and expiration (12/10/2027). It also includes a note that the sale price is a weighted average and that granular price-level data can be provided on request. The filing was executed by an attorney-in-fact, with signature dated 08/22/2025, consistent with procedural norms. There are no indications of hedging arrangements or additional agreements in this document.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (Right to Buy) - BATRK | 60,000 | $0.00 | $0.00 |
| Exercise | Series C Common Stock | 60,000 | $27.18 | $1.63M |
| Sale | Series C Common Stock | 60,000 | $43.45 | $2.61M |
Footnotes (1)
- F1. Reflects the weighted average sale price. The range of prices for such transaction is $43.09 to $43.70. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
AI-generated analysis. How Rhea-AI works. Not financial advice.
